Figure 1.
Crude incidence rates of clinical end points across biomarker quartiles. Quartile cut points were defined differently for each study, as described in Supplementary Table 2. Abbreviations: CI, confidence interval; hsCRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; PYFU, person-years of follow-up.